User:Niwot/Personal sandbox/Iluvien sub page

Iluvien™ (fluocinolone acetonide) Intravitreal Insert is a medication-infused polymer insert designed to be injected into the the fluid inside the human eye by an ophthalmologist specializing in diseases of the retina. This tiny insert, 1/24th the size of a grain of rice, after insertion, delivers a reliably low, effective dose of fluocinolone directly to the back (retina) of the eye for the treatment of Diabetic Macular Edema (DME). The low dose delivery lasts for 3 years before another Iluvien™ insert is injected to maintain the therapeutic dose. Not fully approved by the U.S. Food and Drug Administration (FDA) as yet, Iluvien™ is currently in Phase III Human testing. It is being developed by Alimera Sciences, Inc., Alpharetta, Georgia, USA.